ペプチドリームの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/24 | 1,318 | 1,341 | 1,300 | 1,337 | +79 | +6.3% | 1,566,500 |
| 2022/06/23 | 1,265 | 1,281 | 1,253 | 1,258 | -27 | -2.1% | 1,061,600 |
| 2022/06/22 | 1,284 | 1,295 | 1,256 | 1,285 | +14 | +1.1% | 1,109,400 |
| 2022/06/21 | 1,242 | 1,291 | 1,242 | 1,271 | +49 | +4% | 922,300 |
| 2022/06/20 | 1,264 | 1,269 | 1,204 | 1,222 | -16 | -1.3% | 1,122,000 |
| 2022/06/17 | 1,234 | 1,254 | 1,217 | 1,238 | -37 | -2.9% | 1,646,700 |
| 2022/06/16 | 1,337 | 1,343 | 1,271 | 1,275 | -43 | -3.3% | 1,435,200 |
| 2022/06/15 | 1,300 | 1,329 | 1,297 | 1,318 | +18 | +1.4% | 1,321,200 |
| 2022/06/14 | 1,328 | 1,348 | 1,276 | 1,300 | -60 | -4.4% | 1,861,700 |
| 2022/06/13 | 1,439 | 1,443 | 1,359 | 1,360 | -125 | -8.4% | 1,830,100 |
| 2022/06/10 | 1,520 | 1,525 | 1,481 | 1,485 | -64 | -4.1% | 867,800 |
| 2022/06/09 | 1,500 | 1,557 | 1,493 | 1,549 | +62 | +4.2% | 1,091,400 |
| 2022/06/08 | 1,459 | 1,501 | 1,448 | 1,487 | +19 | +1.3% | 1,015,200 |
| 2022/06/07 | 1,447 | 1,484 | 1,432 | 1,468 | +23 | +1.6% | 1,061,700 |
| 2022/06/06 | 1,478 | 1,489 | 1,440 | 1,445 | -61 | -4.1% | 1,367,900 |
| 2022/06/03 | 1,525 | 1,553 | 1,495 | 1,506 | -4 | -0.3% | 1,184,000 |
| 2022/06/02 | 1,584 | 1,584 | 1,505 | 1,510 | -105 | -6.5% | 1,292,300 |
| 2022/06/01 | 1,602 | 1,648 | 1,599 | 1,615 | +4 | +0.2% | 752,100 |
| 2022/05/31 | 1,650 | 1,655 | 1,590 | 1,611 | -32 | -1.9% | 1,356,900 |
| 2022/05/30 | 1,580 | 1,648 | 1,565 | 1,643 | +96 | +6.2% | 1,303,400 |
| 2022/05/27 | 1,617 | 1,618 | 1,526 | 1,547 | -35 | -2.2% | 962,500 |
| 2022/05/26 | 1,623 | 1,671 | 1,579 | 1,582 | -30 | -1.9% | 843,600 |
| 2022/05/25 | 1,662 | 1,685 | 1,612 | 1,612 | -60 | -3.6% | 940,400 |
| 2022/05/24 | 1,696 | 1,730 | 1,657 | 1,672 | -64 | -3.7% | 915,700 |
| 2022/05/23 | 1,687 | 1,747 | 1,682 | 1,736 | +105 | +6.4% | 1,121,600 |
| 2022/05/20 | 1,582 | 1,647 | 1,568 | 1,631 | +67 | +4.3% | 1,039,000 |
| 2022/05/19 | 1,600 | 1,615 | 1,561 | 1,564 | -94 | -5.7% | 1,347,900 |
| 2022/05/18 | 1,727 | 1,754 | 1,654 | 1,658 | -59 | -3.4% | 1,071,800 |
| 2022/05/17 | 1,764 | 1,770 | 1,716 | 1,717 | -58 | -3.3% | 759,400 |
| 2022/05/16 | 1,833 | 1,878 | 1,774 | 1,775 | -18 | -1% | 692,100 |
| 2022/05/13 | 1,745 | 1,836 | 1,738 | 1,793 | -3 | -0.2% | 925,100 |
| 2022/05/12 | 1,860 | 1,876 | 1,787 | 1,796 | -136 | -7% | 863,200 |
| 2022/05/11 | 1,921 | 1,941 | 1,860 | 1,932 | +34 | +1.8% | 551,500 |
| 2022/05/10 | 1,900 | 1,912 | 1,835 | 1,898 | -51 | -2.6% | 984,000 |
| 2022/05/09 | 1,900 | 1,969 | 1,900 | 1,949 | +5 | +0.3% | 710,300 |
| 2022/05/06 | 1,989 | 1,998 | 1,924 | 1,944 | -92 | -4.5% | 1,022,900 |
| 2022/05/02 | 2,071 | 2,071 | 2,011 | 2,036 | -66 | -3.1% | 659,500 |
| 2022/04/28 | 2,070 | 2,113 | 2,028 | 2,102 | +37 | +1.8% | 627,000 |
| 2022/04/27 | 2,031 | 2,070 | 1,991 | 2,065 | -42 | -2% | 988,700 |
| 2022/04/26 | 2,055 | 2,114 | 2,028 | 2,107 | +182 | +9.5% | 1,203,900 |
| 2022/04/25 | 1,900 | 1,953 | 1,898 | 1,925 | -4 | -0.2% | 554,100 |
| 2022/04/22 | 1,959 | 1,967 | 1,904 | 1,929 | -70 | -3.5% | 639,600 |
| 2022/04/21 | 1,987 | 2,007 | 1,964 | 1,999 | -3 | -0.1% | 572,400 |
| 2022/04/20 | 1,996 | 2,024 | 1,963 | 2,002 | -22 | -1.1% | 795,000 |
| 2022/04/19 | 2,099 | 2,124 | 2,022 | 2,024 | -88 | -4.2% | 791,600 |
| 2022/04/18 | 2,140 | 2,160 | 2,106 | 2,112 | -53 | -2.4% | 479,700 |
| 2022/04/15 | 2,195 | 2,207 | 2,152 | 2,165 | -80 | -3.6% | 404,900 |
| 2022/04/14 | 2,259 | 2,259 | 2,184 | 2,245 | -1 | ±0% | 518,500 |
| 2022/04/13 | 2,132 | 2,260 | 2,132 | 2,246 | +110 | +5.1% | 568,700 |
| 2022/04/12 | 2,156 | 2,179 | 2,112 | 2,136 | -77 | -3.5% | 557,600 |
701～
750
件表示中 / 2908件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.13倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
